The Patent Finder

Anamar AB

Also on record
Records under this name other than the patents Anamar AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Back to Anamar AB

PatentTitleStatus Expires Confidence
US 9,632,097Determining Pathological Cartilage Turnover
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,410,174Method for treating arthritis
Formerly held
Lapsed on the fee record
Ended Apr 2, 2021 · From the USPTO record
Lapsed on the fee recordEnded Apr 2, 2021From the USPTO record
US 8,372,878Aminoguanidines as melanocortin receptor ligands
Formerly held
Lapsed on the fee record
Ended Feb 12, 2021 · From the USPTO record
Lapsed on the fee recordEnded Feb 12, 2021From the USPTO record
US 8,110,663Monoclonal antibodies for cartillage oligomeric matrix protein
Term ended
Term ended Nov 22, 2020 · From the USPTO record
Term endedTerm ended Nov 22, 2020From the USPTO record
US 8,309,609Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
Formerly held
Lapsed on the fee record
Ended Nov 13, 2020 · From the USPTO record
Lapsed on the fee recordEnded Nov 13, 2020From the USPTO record
US 8,227,502Amides acting on the adenosine receptors
Formerly held
Lapsed on the fee record
Ended Jul 24, 2020 · From the USPTO record
Lapsed on the fee recordEnded Jul 24, 2020From the USPTO record
US 8,148,429Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
Formerly held
Lapsed on the fee record
Ended Apr 3, 2020 · From the USPTO record
Lapsed on the fee recordEnded Apr 3, 2020From the USPTO record
US 9,227,927Method of treating inflammation
Formerly held
Lapsed on the fee record
Ended Jan 5, 2020 · From the USPTO record
Lapsed on the fee recordEnded Jan 5, 2020From the USPTO record
US 7,956,047Use of chondroitin sulphate E (CS-E) for the treatment of diseases or conditions related to collagen fibril formation
Formerly held
Lapsed on the fee record
Ended Jun 7, 2019 · From the USPTO record
Lapsed on the fee recordEnded Jun 7, 2019From the USPTO record
US 7,153,881Compounds acting as melanocortin receptor ligands
Formerly held
Lapsed on the fee record
Ended Dec 26, 2018 · From the USPTO record
Lapsed on the fee recordEnded Dec 26, 2018From the USPTO record
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited